GAD2 and stiff-person syndrome: Autoantibodies against GAD65 are common at the onset of type I diabetes but have also been reported in various neurological disorders, such as stiff person syndrome, cerebral ataxia, and, in some cases, in epilepsy and limbic encephalitis [58,59].